| scholarly article | Q13442814 |
| P2093 | author name string | Toshiharu Sakurai | |
| Hiroaki Higashitsuji | |||
| Jun Fujita | |||
| R John Mayer | |||
| Katsuhiko Itoh | |||
| Kohsuke Nonoguchi | |||
| Toshikazu Nagao | |||
| Simon Dawson | |||
| P2860 | cites work | Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas | Q22010990 |
| Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb | Q24292483 | ||
| A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| Surfing the p53 network | Q28032484 | ||
| NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis | Q28138611 | ||
| Physical and functional interactions of neuronal growth suppressor necdin with p53 | Q28144785 | ||
| Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
| Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome | Q28214769 | ||
| Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death | Q28215693 | ||
| The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse | Q28509419 | ||
| Cancer. Addiction to oncogenes--the Achilles heal of cancer | Q29614243 | ||
| Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance | Q34144126 | ||
| A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis | Q34156179 | ||
| The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease | Q34561533 | ||
| Modelling the molecular circuitry of cancer | Q34665971 | ||
| Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells | Q37352612 | ||
| Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro | Q37459913 | ||
| Cdc6 requires anchorage for its expression | Q40744417 | ||
| A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes | Q41481423 | ||
| Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular | Q43574623 | ||
| High frequency of expression of MAGE genes in human hepatocellular carcinoma. | Q57205523 | ||
| Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy | Q74335031 | ||
| Expression of the MAGE gene family in human hepatocellular carcinoma | Q77214108 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10668-74 | |
| P577 | publication date | 2003-03-21 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity | |
| P478 | volume | 278 |
| Q24305959 | A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells |
| Q37072996 | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis |
| Q39415233 | Adriamycin enhances proteasome-mediated generation of the proapoptotic processed form of MAGE-A4 in hepatoma cells |
| Q34032518 | An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients. |
| Q37212693 | Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines |
| Q48138281 | Biosilica formation in spicules of the sponge Suberites domuncula: synchronous expression of a gene cluster |
| Q38053488 | Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability. |
| Q36425935 | Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer. |
| Q38053489 | Cancer testis antigens: a novel target in lung cancer. |
| Q37737327 | Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment |
| Q53338076 | Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. |
| Q38403243 | Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients. |
| Q29616129 | Cancer/testis antigens, gametogenesis and cancer |
| Q40738333 | Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies |
| Q33420388 | Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer |
| Q36745375 | Coping with stress: multiple ways to activate p53. |
| Q39043145 | Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance. |
| Q41982097 | Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. |
| Q39159064 | Effects of CT-Xp gene knock down in melanoma cell lines |
| Q38445389 | Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck |
| Q64264599 | Expression dynamics of family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells |
| Q34111764 | Expression of cancer-testis (CT) antigens in placenta |
| Q80559045 | Expression of cancer-testis antigen CT7 (MAGE-C1) in breast cancer: an immunohistochemical study with emphasis on prognostic utility |
| Q82507005 | Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma |
| Q35116913 | Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks |
| Q33700477 | Frequent MAGE Mutations in Human Melanoma |
| Q98291007 | Gankyrin Oncoprotein: Structure, Function, and Involvement in Cancer |
| Q40068246 | Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance |
| Q92518059 | Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling |
| Q39586309 | Identification of two novel HLA-A*0201-restricted CTL epitopes derived from MAGE-A4. |
| Q34770928 | Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation |
| Q39089829 | MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma. |
| Q34217938 | MAGE-A family: attractive targets for cancer immunotherapy |
| Q24301553 | MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription |
| Q24298306 | MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs |
| Q36503123 | Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model |
| Q39880807 | Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells |
| Q37873931 | Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond |
| Q35933899 | Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding |
| Q90429861 | The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy |
| Q24646394 | The ankyrin repeat as molecular architecture for protein recognition |
| Q37849976 | The biology of cancer testis antigens: putative function, regulation and therapeutic potential |
| Q27642398 | The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53 |
| Q90652334 | The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading |
| Q83291299 | The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients |
| Q24307855 | The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53 |
| Q33555751 | Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers |
| Q34399765 | Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy |
| Q40364292 | p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cells |
Search more.